A number of firms have modified their ratings and price targets on shares of RXO (NYSE: RXO) recently:
- 1/15/2026 – RXO had its “hold” rating reaffirmed by analysts at Benchmark Co..
- 1/15/2026 – RXO had its price target lowered by analysts at Truist Financial Corporation from $20.00 to $18.00. They now have a “buy” rating on the stock.
- 1/9/2026 – RXO had its “hold” rating reaffirmed by analysts at Cowen Inc.
- 1/9/2026 – RXO was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating.
- 1/9/2026 – RXO had its price target raised by analysts at TD Cowen from $13.00 to $14.00. They now have a “hold” rating on the stock.
- 1/8/2026 – RXO had its price target raised by analysts at Susquehanna from $10.00 to $11.00. They now have a “negative” rating on the stock.
- 1/8/2026 – RXO had its price target lowered by analysts at Citigroup Inc. from $16.00 to $15.00. They now have a “neutral” rating on the stock.
- 12/22/2025 – RXO had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
- 12/16/2025 – RXO had its price target raised by analysts at Stifel Nicolaus from $15.00 to $16.00. They now have a “hold” rating on the stock.
- 12/15/2025 – RXO had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
- 12/12/2025 – RXO had its “hold” rating reaffirmed by analysts at Benchmark Co..
- 12/8/2025 – RXO had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
- 12/5/2025 – RXO was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating.
- 11/24/2025 – RXO had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
Insider Transactions at RXO
In related news, CEO Andrew M. Wilkerson purchased 7,775 shares of the firm’s stock in a transaction on Monday, November 10th. The shares were acquired at an average price of $12.88 per share, for a total transaction of $100,142.00. Following the purchase, the chief executive officer directly owned 7,775 shares in the company, valued at $100,142. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Thomas A. Szlosek acquired 20,308 shares of the firm’s stock in a transaction on Friday, November 7th. The shares were bought at an average price of $12.37 per share, for a total transaction of $251,209.96. Following the completion of the transaction, the director owned 36,508 shares of the company’s stock, valued at approximately $451,603.96. This trade represents a 125.36% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 40,250 shares of company stock worth $488,875 in the last quarter. Company insiders own 1.48% of the company’s stock.
Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.
Further Reading
- Five stocks we like better than RXO
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Rxo Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rxo Inc and related companies with MarketBeat.com's FREE daily email newsletter.
